Wednesday, January 20, 2016
OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer
… are being conducted to evaluate tumor response rates, safety, tolerability, and … underway in bladder, lung and prostate cancers. For more information on apatorsen … castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment